Table of Contents
Chemotherapy Research and Practice
Volume 2011 (2011), Article ID 125192, 7 pages
http://dx.doi.org/10.1155/2011/125192
Review Article

Lipoplatin Treatment in Lung and Breast Cancer

1Department of Oncology and Oncohematology, Infermi Hospital, 2 Settembrini Street, 47900 Rimini, Italy
2Department of Oncology, Cervesi Hospital, 1 Beethoven Street, 47841 Cattolica, Italy
3The Cancer Institute of Romagna IRST, 40 Piero Maroncelli Street, 47041 Meldola, Italy

Received 1 September 2010; Accepted 14 December 2010

Academic Editor: Vassilis Georgoulias

Copyright © 2011 Manuela Fantini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Immordino, F. Dosio, and L. Cattel, “Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential,” International Journal of Nanomedicine, vol. 1, no. 3, pp. 297–315, 2006. View at Google Scholar · View at Scopus
  2. G. P. Stathopoulos, T. Boulikas, M. Vougiouka et al., “Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study,” Oncology reports, vol. 13, no. 4, pp. 589–595, 2005. View at Google Scholar · View at Scopus
  3. M. E. Froudarakis, A. Pataka, P. Pappas et al., “Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma,” Cancer, vol. 113, no. 10, pp. 2752–2760, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. G. P. Stathopoulos, T. Boulikas, M. Vougiouka, S. K. Rigatos, and J. G. Stathopoulos, “Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: a phase I-II study,” Oncology Reports, vol. 15, no. 5, pp. 1201–1204, 2006. View at Google Scholar · View at Scopus
  5. A. Ravaioli, M. Papi, E. Pasquini et al., “Lipoplatin monotherapy: a phase II trial of second-line treatment of metastatic non-small-cell lung cancer,” Journal of Chemotherapy, vol. 21, no. 1, pp. 86–90, 2009. View at Google Scholar · View at Scopus
  6. S. Anevlavis, A. Pataka, G. Kouliatsis et al., “A phase II trial of Lipoplatin-gemcitabine in patients with advanced NSCLC: preliminary results,” European Respiratory Journal, vol. 32, p. 762s, 2008. View at Google Scholar
  7. N. Mylonakis, A. Athanasiou, N. Ziras et al., “Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer,” Lung Cancer, vol. 68, no. 2, pp. 240–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Farhat, J. Kattan, K. Ibrahim et al., “Preliminary results of a Phase II study of lipoplatin (liposomal cisplatin)-vinorelbine combination as first line treatment in HER2/neu negative metastatic breast cancer (MBC),” Eur J Cancer, vol. 8, no. 3, p. 192s, 2010. View at Google Scholar
  9. M. I. Koukourakis, A. Giatromanolaki, M. Pitiakoudis et al., “Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study,” International Journal of Radiation Oncology, Biology, Physics, vol. 78, no. 1, pp. 150–155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. F. Jehn, T. Boulikas, A. Kourvetaris, G. Kofla, K. Possinger, and D. Lüftner, “First safety and response results of a randomized phase III study with liposomal platin in the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN),” Anticancer Research, vol. 28, no. 6B, pp. 3961–3964, 2008. View at Google Scholar · View at Scopus
  11. C. Kosmas, J. Angel, A. Athanasiou et al., “Phase III study of Lipoplatin plus Gemcitabine versus Cisplatin plus Gemcitabine in advanced NSCLC; interim analysis,” European Journal of Cancer Supplements, vol. 7, no. 2, p. 531, 2009. View at Google Scholar
  12. G. P. Stathopoulos, D. Antoniou, J. Dimitroulis et al., “Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial,” Annals of Oncology, vol. 21, no. 11, pp. 2227–2232, 2010. View at Publisher · View at Google Scholar
  13. T. Boulikas, N. Mylonakis, G. Sarikos et al., “Superiority of Lipoplatin plus gemcitabine compared to cisplatin plus gemcitabine as first-line treatment against NSCLC: preliminary results of a randomized, multicenter phase III trial,” Journal of Clinical Oncology, vol. 25, no. 18S, p. 180, 2007. View at Google Scholar
  14. G. Stathopoulos, D. Antoniou, J. Dimitroulis et al., “Comparison of response rate of advanced non-small lung cancer patients to liposomal cisplatin versus cisplatin both combined with paclitaxel: a phase III trial,” Journal of Clinical Oncology, vol. 28, no. 7s, abstract 7579, 2010. View at Google Scholar